曾莲. 甲氨蝶呤肌注联合米非司酮口服治疗异位妊娠的疗效及安全性[J]. 实用临床医药杂志, 2019, 23(20): 49-52. DOI: 10.7619/jcmp.201920014
引用本文: 曾莲. 甲氨蝶呤肌注联合米非司酮口服治疗异位妊娠的疗效及安全性[J]. 实用临床医药杂志, 2019, 23(20): 49-52. DOI: 10.7619/jcmp.201920014
ZENG Lian. Efficacy and safety of methotrexate intramuscular injection combined with mifepristone oral administration for ectopic pregnancy[J]. Journal of Clinical Medicine in Practice, 2019, 23(20): 49-52. DOI: 10.7619/jcmp.201920014
Citation: ZENG Lian. Efficacy and safety of methotrexate intramuscular injection combined with mifepristone oral administration for ectopic pregnancy[J]. Journal of Clinical Medicine in Practice, 2019, 23(20): 49-52. DOI: 10.7619/jcmp.201920014

甲氨蝶呤肌注联合米非司酮口服治疗异位妊娠的疗效及安全性

Efficacy and safety of methotrexate intramuscular injection combined with mifepristone oral administration for ectopic pregnancy

  • 摘要:
      目的  探讨甲氨蝶呤肌注联合米非司酮口服治疗对异位妊娠的疗效及安全性。
      方法  选择42例异位妊娠患者作为研究对象,根据随机数表法将其分为对照组、观察组,各21例。对照组肌注甲氨蝶呤,观察组在对照组治疗基础上再口服米非司酮。观察并比较2组治疗后的效果,治疗前后的包块直径、血β-人绒毛膜促性腺激素(β-HCG), 住院、月经恢复、腹痛及包块消失时间,以及不良反应发生情况。
      结果  观察组总有效率为90.48%, 显著高于对照组的61.90%(P < 0.05)。治疗前, 2组的包块直径、血β-HCG值无显著差异(P>0.05); 治疗后,观察组的包块直径、血β-HCG值显著小于对照组(P < 0.05)。观察组的住院、月经恢复、腹痛及包块消失时间均显著短于对照组(P < 0.05)。观察组不良反应发生率略高于对照组,但差异无统计学意义(P>0.05)。
      结论  异位妊娠患者采用肌注甲氨蝶呤联合口服米非司酮治疗的效果显著,起效快,且安全性高。

     

    Abstract:
      Objective   To study the efficacy and safety of methotrexate intramuscular injection combined with oral mifepristone oral administration in the treatment of ectopic pregnancy.
      Methods   A total of 42 patients with ectopic pregnancy in our hospital were selected for the study. According to the random number table method, the patients were divided into control group and observation group, with 21 cases per group. The control group was given intramuscular injection of methotrexate, while the observation group was given mifepristone orally on the basis of the control group. The treatment efficacy, the diameter of mass, blood Blood β-human chorionic gonadotropin (β-HCG) value, hospital stay, menstrual recovery time, disappearance time of abdominal pain and mass, and adverse reactions were observed before and after treatment.
      Results   The total effective rate of the observation group was significantly higher than that of the control group (90.48% vs. 61.90%, P < 0.05). Before treatment, there were no significant differences in the diameter of mass and blood β-HCG between the two groups (P>0.05). After treatment, the above indicators in the observation group were significantly lower than that in the control group(P < 0.05). The hospital stay, menstrual recovery time, disappearance time of abdominal pain and mass were significantly shorter than that in the control group (P < 0.05). The incidence of adverse reactions in the observation group was slightly higher than that in the control group, but there was no significant difference between the two groups (P>0.05).
      Conclusion   Methotrexate injection combined with oral mifepristone, characterized by quick onset and higher safety, has remarkable effect for patients with ectopic pregnancy.

     

/

返回文章
返回